Kristin P. Bibee, Ph.D.
Affiliations: | 2013 | Biology & Biomedical Sciences (Molecular Cell Biology) | Washington University, Saint Louis, St. Louis, MO |
Area:
Cell Biology, Nanotechnology, Medicine and SurgeryGoogle:
"Kristin Bibee"Parents
Sign in to add mentor| Samuel A. Wickline | grad student | 2013 | Washington University | |
| (Cargo and Carrier Effects of Rapamycin-Loaded Perfluorocarbon Nanoparticles.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bibee KP, Cheng YJ, Ching JK, et al. (2014) Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 2047-61 |
| Zhang H, Zhang L, Myerson J, et al. (2011) Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents. Plos One. 6: e26385 |
| Sim H, Bibee K, Wickline S, et al. (2011) Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy. Cancer Research. 71: 686-92 |
| Zhang L, Zhang H, Bibee K, et al. (2010) Quantitative molecular imaging of atherosclerotic endothelial dysfunction with perfluorocarbon (19F) nanoparticle magnetic resonance imaging and spectroscopy Journal of Cardiovascular Magnetic Resonance. 12 |
| Bibee K, Li A, Wickline S. (2010) Abstract P2-19-02: mTOR Pathway Inhibitor Nanoparticles Beneficially Modulate Autophagy in Triple Negative Breast Cancer Cells Cancer Research. 70 |